243 related articles for article (PubMed ID: 6245355)
1. Facilitatory effects of 4-aminopyridine on neuromuscular transmission in disease states.
Kim YI; Goldner MM; Sanders DB
Muscle Nerve; 1980; 3(2):112-9. PubMed ID: 6245355
[TBL] [Abstract][Full Text] [Related]
2. Facilitatory effects of 4-aminopyridine on normal neuromuscular transmission.
Kim YI; Goldner MM; Sanders DB
Muscle Nerve; 1980; 3(2):105-11. PubMed ID: 6245354
[TBL] [Abstract][Full Text] [Related]
3. Acetylcholine release in diaphragm of rats with chronic experimental autoimmune myasthenia gravis.
Kelly JJ; Lambert EH; Lennon VA
Ann Neurol; 1978 Jul; 4(1):67-72. PubMed ID: 211931
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic and postsynaptic actions of procainamide on neuromuscular transmission.
Lee DC; Kim YI; Liu HH; Johns TR
Muscle Nerve; 1983; 6(6):442-7. PubMed ID: 6312309
[TBL] [Abstract][Full Text] [Related]
5. Short-term effects of prednisolone on neuromuscular transmission in normal rats and those with experimental autoimmune myasthenia gravis.
Kim YI; Goldner MM; Sanders DB
J Neurol Sci; 1979 Apr; 41(2):223-34. PubMed ID: 220391
[TBL] [Abstract][Full Text] [Related]
6. Passive transfer of the Lambert-Eaton myasthenic syndrome: neuromuscular transmission in mice injected with plasma.
Kim YI
Muscle Nerve; 1985 Feb; 8(2):162-72. PubMed ID: 2997605
[TBL] [Abstract][Full Text] [Related]
7. Effects of 4-aminopyridine and 3,4-diaminopyridine on transmitter release at the neuromuscular junction.
Thomsen RH; Wilson DF
J Pharmacol Exp Ther; 1983 Oct; 227(1):260-5. PubMed ID: 6137556
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic aspects of disorders of neuromuscular transmission. 2. Experimental autoimmune myasthenia gravis and the Lambert-Eaton myasthenic syndrome].
Andreis I; Lovnićki TJ; Beara N; Taradi M
Lijec Vjesn; 1994; 116(5-6):158-61. PubMed ID: 7968205
[TBL] [Abstract][Full Text] [Related]
9. Increase in transmitter release from motor nerve terminals induced by some pyridine derivatives.
Montoya GA; Molgó J; Lemeignan M; Lechat P
Acta Physiol Pharmacol Latinoam; 1984; 34(4):409-18. PubMed ID: 6242265
[TBL] [Abstract][Full Text] [Related]
10. Methylmercury-induced depression of neuromuscular transmission in the rat.
Atchison WD; Narahashi T
Neurotoxicology; 1982 Nov; 3(3):37-50. PubMed ID: 6298679
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous transmitter release in experimental neuromuscular disorders of the rat.
Thesleff SW
Muscle Nerve; 1982; 5(9S):S12-6. PubMed ID: 6302487
[TBL] [Abstract][Full Text] [Related]
12. Neostigmine-induced alterations at the mammalian neuromuscular junction. I. Muscle contraction and electrophysiology.
Tiedt TN; Albuquerque EX; Hudson CS; Rash JE
J Pharmacol Exp Ther; 1978 May; 205(2):326-39. PubMed ID: 205647
[TBL] [Abstract][Full Text] [Related]
13. Effects of D-penicillamine on neuromuscular transmission in rats.
Aldrich MS; Kim YI; Sanders DB
Muscle Nerve; 1979; 2(3):180-5. PubMed ID: 228187
[TBL] [Abstract][Full Text] [Related]
14. Autoimmune disorders of neuromuscular transmission.
Mahadeva B; Phillips LH; Juel VC
Semin Neurol; 2008 Apr; 28(2):212-27. PubMed ID: 18351523
[TBL] [Abstract][Full Text] [Related]
15. A new myasthenic syndrome with end-plate acetylcholinesterase deficiency, small nerve terminals, and reduced acetylcholine release.
Engel AG; Lambert EH; Gomez MR
Ann Neurol; 1977 Apr; 1(4):315-30. PubMed ID: 214017
[TBL] [Abstract][Full Text] [Related]
16. End-plate voltage-gated sodium channels are lost in clinical and experimental myasthenia gravis.
Ruff RL; Lennon VA
Ann Neurol; 1998 Mar; 43(3):370-9. PubMed ID: 9506554
[TBL] [Abstract][Full Text] [Related]
17. Experimental autoimmune myasthenia gravis: a sequential and quantitative study of the neuromuscular junction ultrastructure and electrophysiologic correlations.
Engel AG; Tsujihata M; Lambert EH; Lindstrom JM; Lennon VA
J Neuropathol Exp Neurol; 1976; 35(5):569-87. PubMed ID: 956872
[TBL] [Abstract][Full Text] [Related]
18. Increased expression of rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia gravis.
Losen M; Stassen MH; Martínez-Martínez P; Machiels BM; Duimel H; Frederik P; Veldman H; Wokke JH; Spaans F; Vincent A; De Baets MH
Brain; 2005 Oct; 128(Pt 10):2327-37. PubMed ID: 16150851
[TBL] [Abstract][Full Text] [Related]
19. [Effect of colchicine on rat neuromuscular transmission].
Gao TM; Chen ZX; Sun WY
Sheng Li Xue Bao; 1991 Jun; 43(3):236-42. PubMed ID: 1664975
[TBL] [Abstract][Full Text] [Related]
20. The effects of myasthenic immunoglobulin G on neuromuscular transmission in mouse diaphragm.
Chiu HC; Chen ML; Tsai MC
Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):217-23. PubMed ID: 2827968
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
